BioStock: Chordate Medical's CEO on advancement in Saudi Arabia

Chordate Medical has high market activity in Saudi Arabia, which is exemplified by the reimbursement code that the company’s distributor gained access to during autumn 2020 for a number of private hospitals. In addition, the company’s rhinitis treatment is currently being tested in public hospitals in Saudi Arabia. BioStock contacted Chordate Medical’s CEO Anders Weilandt to learn more about the potential in Saudi Arabia.

Read the full article at biostock.se:

https://www.biostock.se/en/chordate-medicals-ceo-on-advancement-in-saudi-arabia/
 
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se